Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets
Condition(s):Pulmonary Arterial HypertensionLast Updated:December 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary Arterial HypertensionLast Updated:December 28, 2023Completed
Condition(s):Scleroderma; Digital UlcersLast Updated:September 24, 2019Completed
Condition(s):Drug Drug Interaction; Safety IssuesLast Updated:April 4, 2022Completed
Condition(s):Healthy SubjectsLast Updated:February 8, 2018Completed
Condition(s):Sickle Cell DiseaseLast Updated:July 19, 2023Completed
Condition(s):Hypertension, Pulmonary; Altitude SicknessLast Updated:April 12, 2017Completed
Condition(s):Hypertension, Pulmonary; Heart Failure With Normal Ejection FractionLast Updated:November 4, 2020Completed
Condition(s):Hypertension, PulmonaryLast Updated:January 29, 2024Completed
Condition(s):Hypertension, PulmonaryLast Updated:May 24, 2017Completed
Condition(s):Hypertension, PulmonaryLast Updated:January 29, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.